---
title: "Affluent Medical Discloses Share Capital and Voting Rights Details"
date: "2025-02-14 01:15:26"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioAn announcement from Affluent Medical SA..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1110645284-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

An announcement from Affluent Medical SA ( [(FR:AFME)](https://www.tipranks.com/stocks/fr:afme) ) is now available.

Affluent Medical has disclosed the number of shares and voting rights as of January 31, 2025, which includes 39,348,185 shares and 55,576,930 theoretical voting rights. The announcement provides transparency for stakeholders regarding the company’s capital structure and aligns with regulatory requirements.

**More about Affluent Medical SA**

Affluent Medical is a French medical technology company focused on developing innovative treatments for structural heart diseases and urinary incontinence. Founded by Truffle Capital, the company aims to become a global leader by offering new generation, minimally invasive implants that are undergoing clinical trials, with plans for market entry in 2026.

**YTD Price Performance:** 5.56%

**Average Trading Volume:** 1,166

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** €54.07M

For an in-depth examination of AFME stock, go to [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/fr:afme/stock-analysis).

Trending Articles:
------------------

* [Jensen Huang’s Net Worth: The Billionaire Who Leads the World’s Largest Chip Company Nvidia](https://www.tipranks.com/news/jensen-huangs-net-worth-the-billionaire-who-leads-the-worlds-largest-chip-company-nvidia)
* [Super Micro (SMCI) Wins a New Street-High Price Target from Northland Securities](https://www.tipranks.com/news/super-micro-smci-wins-a-new-street-high-price-target-from-northland-securities)
* [3 Penny Stocks to Watch Now, 2/13/25](https://www.tipranks.com/news/3-penny-stocks-to-watch-now-2-13-25)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/affluent-medical-discloses-share-capital-and-voting-rights-details)
